Can thermostable vaccines help address cold-chain challenges? Results from stakeholder interviews in six low- and middle-income countries
This study captures the perspectives of stakeholders at multiple levels of the vaccine supply chain regarding their assessment of challenges with storing vaccines within recommended temperature ranges and their perceptions on the benefits of having vaccines with improved stability, including the potential short-term storage and transport of vaccines in a controlled-temperature chain.
|Disease||Diphtheria , Haemophilus influenzae , Hepititis B , Pertussis , Rotavirus , Tetanus|
|Added on||3 February 2016 07:37:08|
Add to Favourites